Details of the Drug

General Information of Drug (ID: DMO8N8N)

Drug Name

Olipudase alfa

Indication

Disease Entry	ICD 11	Status	REF
Gaucher disease	5C56.0Y	Approved	[1]
Sphingolipidosis	5C56.0	Phase 2	[2]
------------------------------------------------------------------------------------

ATC Code

A16AB25: Olipudase alfa

A16AB: Enzymes

A16A: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

A16: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

A: ALIMENTARY TRACT AND METABOLISM

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Pyruvate kinase PKLR (PKLR)	TT31N4S	KPYR_HUMAN	Activator	[3]
Sphingomyelin phosphodiesterase (SMPD1)	TTJTM88	ASM_HUMAN	Replacement	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761261.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761261